Healthcare -
Biotechnology - NASDAQ - US
$ 15.5
-6.4 %
$ 2.25 B
Market Cap
-6.03
P/E
DNLI - OPERATING EXPENSES
Operating Expenses DNLI - Denali Therapeutics Inc.
527 M
LAST VALUE
23.73%
2 YEAR CAGR
24.60%
5 YEAR CAGR
0.00%
10 YEAR CAGR